» Articles » PMID: 21443669

Liver Cirrhosis in Malaysia: Peculiar Epidemiology in a Multiracial Asian Country

Overview
Specialty Gastroenterology
Date 2011 Mar 30
PMID 21443669
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: To determine the etiology of liver cirrhosis and risk factors for hepatocellular carcinoma (HCC) in a multiracial Asian population.

Methods: Consecutive patients with liver cirrhosis presenting to outpatient clinics and inpatient service at the University of Malaya Medical Centre from 1 April 2006 to 31 May 2009 were included.

Results: A total of 460 patients were included in the study: 317 male patients (68.9%) and 143 female patients (31.1%), with a mean age of 58.8years (range: 15-87years). The major causes of cirrhosis were: chronic hepatitis B, n=212, 46.1%; chronic hepatitis C, n=85, 18.5%; cryptogenic, n=71, 15.4%; alcohol, n=58, 12.6% and autoimmune, n=9, 2.0%. Alcohol was the main etiology in Indians (51.1%) compared to Malay (0%) and Chinese (4.4%) (both P<0.001). Hepatitis B was the predominant etiology in Malay (47.9%) and Chinese (58.8%) compared to Indians (5.6%) (both P<0.001). Hepatitis C cirrhosis was highest in Malays (25.0%). 136 patients (29.6%) had concurrent HCC. Male sex (P<0.001), age>60years (P=0.014), hepatitis B (P<0.001), hepatitis C (P=0.006) and cryptogenic cause (P=0.002) were found to be independent risk factors for HCC.

Conclusions: The etiology of cirrhosis has a peculiar pattern based on racial differences in alcohol intake and in the prevalence of hepatitis B.

Citing Articles

The Epidemiology of Ascites in a Multi-Ethnic Asian Population.

Sinnanaidu R, Poobalan K, Singh A, Nair K, Vijayananthan A, Mahadeva S JGH Open. 2025; 9(2):e70111.

PMID: 39959453 PMC: 11825974. DOI: 10.1002/jgh3.70111.


Coinfection of Hepatitis B and C Viruses and Risk of Hepatocellular Carcinoma: Systematic Review and Meta-analysis.

Awadh A, Alharthi A, Alghamdi B, Alghamdi S, Baqays M, Binrabaa I J Glob Infect Dis. 2025; 16(4):127-134.

PMID: 39886088 PMC: 11775402. DOI: 10.4103/jgid.jgid_211_23.


Application of network pharmacology in traditional Chinese medicine for the treatment of digestive system diseases.

Zheng S, Liang Y, Xue T, Wang W, Li S, Zhang P Front Pharmacol. 2024; 15:1412997.

PMID: 39086391 PMC: 11289720. DOI: 10.3389/fphar.2024.1412997.


Increasing Prevalence and High Survival Rate of Liver Transplanted Patients with NASH and PSC Cirrhosis.

Khajehahmadi Z, Nikeghbalian S, Roshanaei G, Mohagheghi S Arch Iran Med. 2024; 27(1):23-29.

PMID: 38431957 PMC: 10915929. DOI: 10.34172/aim.2024.04.


The Burden of Inappropriate Prescriptions and Predictors for Hospitalized Patients with Liver Cirrhosis in Ethiopia.

Zeleke T, Bazezew Z, Abebe R Hepat Med. 2023; 15:129-140.

PMID: 37790886 PMC: 10542506. DOI: 10.2147/HMER.S423351.